H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 48 Citations 11,593 160 World Ranking 11117 National Ranking 4821

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Immune system

Cell biology, Immunology, Notch signaling pathway, Haematopoiesis and Stem cell are his primary areas of study. His Cell biology research is multidisciplinary, incorporating perspectives in T cell and Genetics, Gene. Ivan Maillard focuses mostly in the field of Immunology, narrowing it down to topics relating to Hematopoietic stem cell transplantation and, in certain cases, Bruton's tyrosine kinase, Graft-versus-host disease, B cell, Tyrosine kinase and Pathogenesis.

His research in Notch signaling pathway intersects with topics in Cancer and Cellular differentiation. He has researched Cellular differentiation in several fields, including Transcription factor and CD8. His biological study spans a wide range of topics, including Progenitor cell, Molecular biology, Leukemia and Cancer research.

His most cited work include:

  • Promising Survival for Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Concomitant Radiation Plus Temozolomide Followed by Adjuvant Temozolomide (686 citations)
  • REGULATION OF LYMPHOID DEVELOPMENT, DIFFERENTIATION, AND FUNCTION BY THE NOTCH PATHWAY (394 citations)
  • Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells (355 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Cell biology, Immunology, Notch signaling pathway, Cancer research and Stem cell. His study looks at the relationship between Cell biology and topics such as Fusion protein, which overlap with Hox gene. His studies deal with areas such as Hematopoietic stem cell transplantation and Graft-versus-host disease as well as Immunology.

He interconnects T cell and Cellular differentiation in the investigation of issues within Notch signaling pathway. As part of the same scientific family, Ivan Maillard usually focuses on Cancer research, concentrating on Leukemia and intersecting with Myeloid leukemia, Chromosomal translocation and DOT1L. The concepts of his Stem cell study are interwoven with issues in Bone marrow and Adult stem cell.

He most often published in these fields:

  • Cell biology (40.09%)
  • Immunology (37.07%)
  • Notch signaling pathway (37.07%)

What were the highlights of his more recent work (between 2018-2021)?

  • Cancer research (31.47%)
  • Cell biology (40.09%)
  • T cell (21.98%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Cancer research, Cell biology, T cell, Leukemia and Internal medicine. His Cancer research research incorporates elements of Proinflammatory cytokine, Graft-versus-host disease and Mixed lymphocyte reaction. His Cell biology research integrates issues from Epigenetics, Cytoskeleton and Gene expression profiling.

His study in T cell is interdisciplinary in nature, drawing from both Stromal cell, CD8, Transplantation, Alloimmunity and Notch signaling pathway. His Notch signaling pathway study is focused on Signal transduction in general. His Leukemia research includes themes of Progenitor cell, Haematopoiesis, Myeloid leukemia and Histone methyltransferase.

Between 2018 and 2021, his most popular works were:

  • Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial. (54 citations)
  • Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies (39 citations)
  • SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation. (35 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Immune system

Ivan Maillard mainly investigates Immunology, Immune system, Notch signaling pathway, T cell and Germinal center. Ivan Maillard has included themes like Cancer and Cohort in his Immunology study. He combines subjects such as Messenger RNA and Cell type with his study of Immune system.

Notch signaling pathway is a subfield of Cell biology that Ivan Maillard explores. He studied Cell biology and Stromal cell that intersect with Cell. His Germinal center research is multidisciplinary, relying on both Neutralizing antibody, Recombinant DNA, Virology, Scleroderma and Graft-versus-host disease.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Promising Survival for Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Concomitant Radiation Plus Temozolomide Followed by Adjuvant Temozolomide

Roger Stupp;Pierre Yves Dietrich;Sandrine Ostermann Kraljevic;Alessia Pica.
Journal of Clinical Oncology (2002)

1077 Citations

REGULATION OF LYMPHOID DEVELOPMENT, DIFFERENTIATION, AND FUNCTION BY THE NOTCH PATHWAY

Ivan Maillard;Terry Fang;Warren S. Pear.
Annual Review of Immunology (2005)

602 Citations

IL-4 Rapidly Produced by Vβ4 Vα8 CD4+ T Cells Instructs Th2 Development and Susceptibility to Leishmania major in BALB/c Mice

Pascal Launois;Ivan Maillard;Sabine Pingel;Kristin G. Swihart.
Immunity (1997)

453 Citations

Notch Signaling in Cancer

Eric J. Allenspach;Ivan Maillard;Jon C. Aster;Warren S. Pear.
Cancer Biology & Therapy (2002)

452 Citations

Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells

Kelli L. VanDussen;Alexis J. Carulli;Theresa M. Keeley;Sanjeevkumar R. Patel.
Development (2012)

449 Citations

Notch signaling controls the generation and differentiation of early T lineage progenitors.

Arivazhagan Sambandam;Ivan Maillard;Valerie P Zediak;Lanwei Xu.
Nature Immunology (2005)

442 Citations

Notch signaling is an important regulator of type 2 immunity

LiLi Tu;Terry C. Fang;David Artis;Olga Shestova.
Journal of Experimental Medicine (2005)

371 Citations

Mitochondrial neurogastrointestinal encephalomyopathy: An autosomal recessive disorder due to thymidine phosphorylase mutations

Ichizo Nishino;Antonella Spinazzola;Alexandros Papadimitriou;Simon Hammans.
Annals of Neurology (2000)

360 Citations

Canonical Notch signaling is dispensable for the maintenance of adult hematopoietic stem cells

Ivan Maillard;Ute Koch;Alexis Dumortier;Olga Shestova.
Cell Stem Cell (2008)

349 Citations

Mastermind critically regulates Notch-mediated lymphoid cell fate decisions

Ivan Maillard;Andrew P. Weng;Andrea C. Carpenter;Carlos G. Rodriguez.
Blood (2004)

349 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Ivan Maillard

Warren S. Pear

Warren S. Pear

University of Pennsylvania

Publications: 56

Bruce R. Blazar

Bruce R. Blazar

University of Minnesota

Publications: 53

Roger Stupp

Roger Stupp

Northwestern University

Publications: 43

Ellen V. Rothenberg

Ellen V. Rothenberg

California Institute of Technology

Publications: 42

Scott A. Armstrong

Scott A. Armstrong

Harvard University

Publications: 42

Juan Carlos Zúñiga-Pflücker

Juan Carlos Zúñiga-Pflücker

Sunnybrook Health Science Centre

Publications: 37

Freddy Radtke

Freddy Radtke

École Polytechnique Fédérale de Lausanne

Publications: 37

Michio Hirano

Michio Hirano

Columbia University

Publications: 37

Jon C. Aster

Jon C. Aster

Brigham and Women's Hospital

Publications: 36

Avinash Bhandoola

Avinash Bhandoola

National Institutes of Health

Publications: 33

Fabienne Tacchini-Cottier

Fabienne Tacchini-Cottier

University of Lausanne

Publications: 31

Hideo Yagita

Hideo Yagita

Juntendo University

Publications: 28

Jacques A. Louis

Jacques A. Louis

Institut Pasteur

Publications: 25

Marcel R.M. van den Brink

Marcel R.M. van den Brink

Memorial Sloan Kettering Cancer Center

Publications: 25

Pavan Reddy

Pavan Reddy

University of Michigan–Ann Arbor

Publications: 23

Stephen C. Blacklow

Stephen C. Blacklow

Harvard University

Publications: 22

Something went wrong. Please try again later.